These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 28933182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and in vitro evaluation of amphiphilic peptides and their nanostructured conjugates.
    Mohammadi S, Shahbazi Mojarrad J, Zakeri-Milani P, Shirani A, Mussa Farkhani S, Samadi N, Valizadeh H.
    Adv Pharm Bull; 2015 Mar; 5(1):41-9. PubMed ID: 25789218
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery.
    Zakeri-Milani P, Najafi-Hajivar S, Sarfraz M, Nokhodchi A, Mohammadi H, Montazersaheb S, Niazi M, Hemmatzadeh M, Soleymani-Goloujeh M, Baradaran B, Shahbazi Mojarrad J, Farshbaf M, Gholikhani T, Valizadeh H.
    Iran J Pharm Res; 2021 Mar; 20(3):506-515. PubMed ID: 34904004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of poly-glutamate on uptake efficiency and cytotoxicity of cell penetrating peptides.
    Farkhani SM, Shirani A, Mohammadi S, Zakeri-Milani P, Shahbazi Mojarrad J, Valizadeh H.
    IET Nanobiotechnol; 2016 Apr; 10(2):87-95. PubMed ID: 27074859
    [Abstract] [Full Text] [Related]

  • 7. Cellular uptake and anti-tumor activity of gemcitabine conjugated with new amphiphilic cell penetrating peptides.
    Zakeri-Milani P, Mussa Farkhani S, Shirani A, Mohammadi S, Shahbazi Mojarrad J, Akbari J, Valizadeh H.
    EXCLI J; 2017 Apr; 16():650-662. PubMed ID: 28694765
    [Abstract] [Full Text] [Related]

  • 8. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H, Wu M, Zhu L, Tian Y, Wu M, Li Y, Deng L, Jiang W, Shen W, Wang Z, Mei Z, Li P, Ran H, Zhou Z, Ren J.
    Theranostics; 2018 Apr; 8(7):1892-1910. PubMed ID: 29556363
    [Abstract] [Full Text] [Related]

  • 9. Twin-Arginine Translocation Peptide Conjugated Epirubicin-Loaded Nanoparticles for Enhanced Tumor Penetrating and Targeting.
    Zhang L, Liu F, Li G, Zhou Y, Yang Y.
    J Pharm Sci; 2015 Dec; 104(12):4185-4196. PubMed ID: 26398477
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells.
    Zakeri-Milani P, Shirani A, Nokhodchi A, Mussa Farkhani S, Mohammadi S, Shahbazi Mojarrad J, Mahmoudian M, Gholikhani T, Farshbaf M, Valizadeh H.
    Drug Dev Ind Pharm; 2020 Apr; 46(4):521-530. PubMed ID: 32116040
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways.
    Dowaidar M.
    Mitochondrion; 2024 Sep; 78():101906. PubMed ID: 38797356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.
    Gronewold A, Horn M, Ranđelović I, Tóvári J, Muñoz Vázquez S, Schomäcker K, Neundorf I.
    ChemMedChem; 2017 Jan 05; 12(1):42-49. PubMed ID: 27860402
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides.
    Vale N, Ferreira A, Fernandes I, Alves C, Araújo MJ, Mateus N, Gomes P.
    Bioorg Med Chem Lett; 2017 Jul 01; 27(13):2898-2901. PubMed ID: 28495087
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.